135 related articles for article (PubMed ID: 30366005)
1. The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats.
Costa G; Serra M; Pintori N; Casu MA; Zanda MT; Murtas D; De Luca MA; Simola N; Fattore L
Neuropharmacology; 2019 Jan; 144():219-232. PubMed ID: 30366005
[TBL] [Abstract][Full Text] [Related]
2. Methoxetamine affects brain processing involved in emotional response in rats.
Zanda MT; Fadda P; Antinori S; Di Chio M; Fratta W; Chiamulera C; Fattore L
Br J Pharmacol; 2017 Oct; 174(19):3333-3345. PubMed ID: 28718892
[TBL] [Abstract][Full Text] [Related]
3. New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT
Marti M; Talani G; Miliano C; Bilel S; Biggio F; Bratzu J; Diana M; De Luca MA; Fattore L
Exp Neurol; 2021 Nov; 345():113836. PubMed ID: 34384790
[TBL] [Abstract][Full Text] [Related]
4. R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine.
Botanas CJ; Perez Custodio RJ; Kim HJ; de la Pena JB; Sayson LV; Ortiz DM; Kim M; Lee HJ; Acharya S; Kim KM; Lee CJ; Ryu JH; Lee YS; Cheong JH
Neuropharmacology; 2021 Aug; 193():108619. PubMed ID: 34023336
[TBL] [Abstract][Full Text] [Related]
5. Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice.
Ossato A; Bilel S; Gregori A; Talarico A; Trapella C; Gaudio RM; De-Giorgio F; Tagliaro F; Neri M; Fattore L; Marti M
Neuropharmacology; 2018 Oct; 141():167-180. PubMed ID: 30165078
[TBL] [Abstract][Full Text] [Related]
6. Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.
Horsley RR; Lhotkova E; Hajkova K; Jurasek B; Kuchar M; Palenicek T
Brain Res Bull; 2016 Sep; 126(Pt 1):102-110. PubMed ID: 27155360
[TBL] [Abstract][Full Text] [Related]
7. The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission.
Mutti A; Aroni S; Fadda P; Padovani L; Mancini L; Collu R; Muntoni AL; Fattore L; Chiamulera C
Psychopharmacology (Berl); 2016 Jun; 233(12):2241-51. PubMed ID: 27020786
[TBL] [Abstract][Full Text] [Related]
8. The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.
Halberstadt AL; Slepak N; Hyun J; Buell MR; Powell SB
Psychopharmacology (Berl); 2016 Apr; 233(7):1215-25. PubMed ID: 26758284
[TBL] [Abstract][Full Text] [Related]
9. Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential.
Botanas CJ; de la Peña JB; Dela Peña IJ; Tampus R; Yoon R; Kim HJ; Lee YS; Jang CG; Cheong JH
Pharmacol Biochem Behav; 2015 Jun; 133():31-6. PubMed ID: 25792291
[TBL] [Abstract][Full Text] [Related]
10. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings.
Zanda MT; Fadda P; Chiamulera C; Fratta W; Fattore L
Behav Pharmacol; 2016 Sep; 27(6):489-96. PubMed ID: 27128862
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
12. Phencyclidine-like in vivo effects of methoxetamine in mice and rats.
Berquist MD; Hyatt WS; Bauer-Erickson J; Gannon BM; Norwood AP; Fantegrossi WE
Neuropharmacology; 2018 May; 134(Pt A):158-166. PubMed ID: 28830759
[TBL] [Abstract][Full Text] [Related]
13. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
14. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
[TBL] [Abstract][Full Text] [Related]
15. Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms.
Botanas CJ; Bryan de la Peña J; Custodio RJ; Joy Dela Peña I; Kim M; Woo T; Kim HJ; Kim HI; Chang Cho M; Lee YS; Cheong JH
Neuropharmacology; 2017 Nov; 126():121-127. PubMed ID: 28867363
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological characterization of the new psychoactive substance methoxetamine.
Hondebrink L; Kasteel EEJ; Tukker AM; Wijnolts FMJ; Verboven AHA; Westerink RHS
Neuropharmacology; 2017 Sep; 123():1-9. PubMed ID: 28454981
[TBL] [Abstract][Full Text] [Related]
18. Methoxetamine: A foe or friend?
Botanas CJ; de la Peña JB; Kim HJ; Lee YS; Cheong JH
Neurochem Int; 2019 Jan; 122():1-7. PubMed ID: 30365979
[TBL] [Abstract][Full Text] [Related]
19. 25C-NBF, a new psychoactive substance, has addictive and neurotoxic potential in rodents.
Hur KH; Kim SE; Lee BR; Ko YH; Seo JY; Kim SK; Ma SX; Kim YJ; Jeong Y; Pham DT; Trinh QD; Shin EJ; Kim HC; Lee YS; Lee SY; Jang CG
Arch Toxicol; 2020 Jul; 94(7):2505-2516. PubMed ID: 32296860
[TBL] [Abstract][Full Text] [Related]
20. Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.
Cadoni C; Pisanu A; Simola N; Frau L; Porceddu PF; Corongiu S; Dessì C; Sil A; Plumitallo A; Wardas J; Di Chiara G
Neuropharmacology; 2017 Sep; 123():385-394. PubMed ID: 28603026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
